(4-(Methoxycarbonyl)-3,5-dimethylphenyl)boronic acid, 95.0%, 5g

Hyperoside, ROTICHROM® HPLC, 10 mg, glass packaging

(2-[4-Benzyl-piperazin-1-yl]-2-oxo-ethyl)-carbamic acid tert-butyl ester, 5g

Beaker ROTILABO® high form, 1000 ml, 10 Piece(s)

2-Amino-4,5,6,7-tetrahydro-benzo[ b ]thiophene-3-carboxylic acid amide, 96.0%, 1g

6,8-Dibromoimidazo[1,2-a]pyrazine>98.0%(GC)5g

Heptan-2-yl 2-chloroacetate, 95+%, 250mg

SODIUM ETHYL SULFATE, 95%, 250mg

2-Bromo-6-fluoronaphthalene, 97.0%, 5g

Ethyl 4-Pentenoate, 97.0%, 1g

(2-butyl-4-chloro-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol, 98%, 100g

N,N-Dimethyl-2-cyanoacetamide, 95.0%, 100g

N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea, 98%, 100mg